Meningitis

Primary Care - Clinics in Office Practice

Volumn 40, Issue 3, 2013, Pages 707-726

  Putz, Katherine ^a   Hayani, Karen ^a   Zar, Fred Arthur ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

Acute meningitis; Aseptic; Blood brain barrier; Cerebrospinal fluid; Meningismus; Prophylaxis; Vaccination

Indexed keywords

ACICLOVIR; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; DEXAMETHASONE; ETHAMBUTOL; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IBUPROFEN; IMMUNOGLOBULIN; ISONIAZID; MENINGOCOCCUS VACCINE; PARACETAMOL; PENICILLIN G; PLECONARIL; PNEUMOCOCCUS VACCINE; PYRAZINAMIDE; RIFAMPICIN; VANCOMYCIN;

ANTIMICROBIAL THERAPY; ARBOVIRUS; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DRUG EFFICACY; ENTEROVIRUS; FEVER; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HERPES VIRUS; HUMAN; MEDICAL HISTORY; MENINGITIS; MENINGOCOCCOSIS; MORBIDITY; MUMPS VIRUS; NEISSERIA MENINGITIDIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PNEUMOCOCCAL INFECTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE;

ACUTE MENINGITIS; ASEPTIC; BLOOD-BRAIN BARRIER; CEREBROSPINAL FLUID; MENINGISMUS; PROPHYLAXIS; VACCINATION;

AGE FACTORS; ANTI-INFECTIVE AGENTS; BRAIN; CEREBROSPINAL FLUID; HAEMOPHILUS VACCINES; HUMANS; MENINGISM; MENINGITIS, ASEPTIC; MENINGITIS, BACTERIAL; PRIMARY HEALTH CARE; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84882238623     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2013.06.001     Document Type: Review

References (62)

1. Khetsuriani N., Quiroz E.S., Holman R.C., et al. Viral meningitis associated hospitalizations in the United States 1988-1999. Neuroepidemiology 2003, 22:345-352.
2. Zaotis T., Klein J.D. Enterovirus infections. Pediatr Rev 1998, 19:183-191.
3. Rotbart H.A. Viral meningitis and the aseptic meningitis syndrome. Infections of the central nervous system 1997, 23-46. Raven, New York. 2nd edition. M. Scheld, R. Whitley, D. Durack (Eds.).
4. Wilfert C.M., Lehrman S.N., Katz S.L. Enteroviruses and meningitis. Pediatr Infect Dis 1983, 2:333-341.
5. Galazka A.M., Robertson S.E., Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999, 77(1):3-14.
6. WHO recommended standards for surveillance of selected vaccine preventable diseases. (2003, February). World Health Organization Home Page. Available at: Accessed January 8, 2013. http://www.who.int/vaccines-documents/.
7. Corey L., Spear P.G. Infections with herpes simplex viruses (2). NEngl J Med 1986, 314:749-757.
8. Corey L., Adams H.G., Brown Z.A., et al. Genital herpes simplex virus infection: clinical manifestations, course and complications. Ann Intern Med 1983, 98:958-972.
9. Bergstrom T., Vahlne A., Alestig K., et al. Primary and recurrent herpes simplex virus type 2-induced meningitis. JInfect Dis 1990, 162:322-330.
10. Mommeja-Marin H., Lafaurie M., Scieux C., et al. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis 2003, 37:1527-1533.
11. Whitley R.J. Viral infections of the central nervous system. Infectious diseases 2004, 267-269. Mosby, London. 2nd edition. J. Cohen, W.G. Powderly (Eds.).
12. CDC Enterovirus surveillance-United States, 1997-1999. MMWR Morb Mortal Wkly Rep 2000, 49:913-916.
13. Rotbart H.A. Enteroviral infections of the central nervous system. Clin Infect Dis 1995, 20:971-981.
14. Johnson R.T. Pathogenesis of CNS infections. Viral infections of the central nervous system 1982, 37-60. Raven, New York. R.T. Johnson (Ed.).
15. Cassady K.A., Whitely R.J. Pathogenesis and pathophysiology of viral infections of the central nervous system. Infections of the central nervous system 2004, 57-74. Lippincott Williams & Wilkins, Philadelphia. 3rd edition. W.M. Scheld, R.J. Whitley, C.M. Marra (Eds.).
16. Brody I.A., Wilkins R.H. The signs of Kernig and Brudzinski. Arch Neurol 1969, 21:215-218.
17. Tunkel A.R., van de Beek D., Scheld M.W. Acute meningitis. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 2009, 1189-1229. Churchill Livingstone Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
18. Norris C.M., Danis P.G., Garder T.D. Aseptic meningitis in the newborn and young infant. Am Fam Physician 1999, 59(10):2761-2770.
19. Connolly K.J., Hammer S.M. The acute aseptic meningitis syndrome. Infect Dis Clin North Am 1990, 4:599-622.
20. Rorabaugh M.L., Berlin L.E., Heldrich F., et al. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 1993, 92:206-211.
21. Wagdhare S., Kalantri A., Joshi R., et al. Accuracy of physical signs for detecting meningitis: a hospital-based diagnostic accuracy study. Clin Neurol Neurosurg 2010, 112:752-757.
22. McKinney R.E., Katz S.L., Wilfert C.M. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis 1987, 9:334-356.
23. Thomas K.E., Hasbun R., Jekel J., et al. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis 2002, 35:46-52.
24. Lin T.Y., Kao H.T., Hsieh S.H., et al. Neonatal enterovirus infections: emphasis on risk factors for severe and fatal infections. Pediatr Infect Dis J 2003, 22:889-894.
25. Modlin J.F. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis 1986, 8:918-926.
26. Azbug M.J. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 2001, 20:758-763.
27. Uchihara T., Tsukagoshi H. Jolt accentuation of headache: the most sensitive sign for CSF pleocytosis. Headache 1991, 31:167-171.
28. Durand M.L., Calderwood S.B., Weber D.J., et al. Acute bacterial meningitis in adults: a review of 493 episodes. NEngl J Med 1993, 328:21-28.
29. Sigurdardottir B., Bjornsson O.M., Jonsdottir K.E., et al. Acute bacterial meningitis in adults: a 20-year overview. Arch Intern Med 1997, 157:425-430.
30. Attia L., Hatala R., Cook D., et al. The rational clinical examination. Does this adult patient have acute meningitis?. JAMA 1999, 282:175-181.
31. Rorabaugh M.L., Berlin L.E., Rosenberg L., et al. Absence of neurodevelopmental sequelae from aseptic meningitis. Pediatr Res 1992, 30:177A.
32. Magnussen C.R. Meningitis in adults: ten-year retrospective analysis at a community hospital. NY State J Med 1980, 80:901-906.
33. Behrman R.E., Meyers B.R., Mendelson M.R., et al. Central nervous system infections in the elderly. Arch Intern Med 1989, 149:1596-1599.
34. Jefferson G. The tentorial pressure cone. Arch Neurol Psychiatry 1938, 40:857-876.
35. Hasbun R., Abrahams J., Jekel J., et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. NEngl J Med 2001, 345:1727-1733.
36. Rotbart H.A., et al. Enteroviruses. Manual of clinical microbiology 1999, 990-998. ASM Press, Washington, DC. P.R. Murray, E.J. Baron, M.A. Pfaller (Eds.).
37. Sawyer M.H., Holland D., Aintablian N. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis J 1994, 3:177-182.
38. Nigrovic L.E., Kupperman N., Macias C.G., Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics, et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk for bacterial meningitis. JAMA 2007, 297(1):52-60.
39. Dubos F., Martinot A., Gendrel D., et al. Clinical decision rules for evaluating meningitis in children. Curr Opin Neurol 2009, 22(3):288-293.
40. Rotbart H.A., Webster A.D., Pleconaril Treatment Registry Group Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis 2001, 22:335-341.
41. Thomson J., Shah S. Viral meningitis. The nervous system. Bope E, Kellerman R; Conn's current therapy 2013 2013, 670-673. Saunders, an imprint of Elsevier, Philadelphia. 1st edition.
42. Bamberger D. Diagnosis, initial management and prevention of meningitis. Am Fam Physician 2010, 82(12):1491-1498.
43. Rotbart H.A., Brennan P.J., Fife K.H., et al. Enterovirus meningitis in adults. Clin Infect Dis 1998, 27:896-898.
44. Parasuraman T.V., Frenia K., Romero J. Enteroviral meningitis. Cost of illness and considerations for the economic evaluations of potential therapies. Pharmacoeconomics 2001, 19:3-12.
45. Thigpen M.C., Whitney C.G., Messonier N.E., et al. Bacterial meningitis in the United States, 1998-2007. NEngl J Med 2011, 364:2016-2025.
46. Schlech W.F., Ward J.I., Band J.D., et al. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA 1985, 253:1749-1754.
47. Wenger J.D., Hightower A.W., Facklam R.R., et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. JInfect Dis 1990, 162:1316.
48. Dery M.A., Hasbun R. Changing epidemiology of bacterial meningitis. Curr Infect Dis Rep 2007, 9:301-307.
49. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998, 11:497-513.
50. Cochi S.L., Broome C.V. Vaccine prevention of Haemophilus influenzae type b disease: past, present and future. Pediatr Infect Dis 1986, 5:12.
51. Centers for Disease Control and Prevention (CDC) Progress toward eliminating Haemophilus influenzae type b disease among infants and children-United States, 1987-1997. MMWR Morb Mortal Wkly Rep 1998, 47:993.
52. Fijen C.A., Kuijper E.J., Tjia H.G., et al. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis 1994, 18:780-784.
53. McClelland S., Hall W.A. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 2007, 45:55-59.
54. Kim K.S. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 2008, 6:625-634.
55. van de Beek D., de Gans J., Spanjaard L., et al. Clinical features and prognostic factors in adults with bacterial meningitis. NEngl J Med 2004, 351:1849-1859.
56. Marx G.E., Chan E.D. Tuberculous meningitis: diagnosis and treatment overview. Tuberc Res Treat 2011, 2011:798764. 10.1155/2011/798764.
57. Reik L. Neurologic abnormalities of Lyme disease. Medicine 1979, 58:281-294.
58. Saravolatz L.D., Manzor O., VanderVelde N., et al. Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis. Clin Infect Dis 2003, 36:40-45.
59. de Gans J., van de Beek D. Dexamethasone in adults with bacterial meningitis. NEngl J Med 2002, 347:1549-1556.
60. Van de Beek D., de Gans J., Tunkel A.R. Community acquired bacterial meningitis in adults. NEngl J Med 2006, 354:44-53.
61. Purcell B., Samuellsson S., Hahne S.J. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ 2004, 328:1339.
62. American Academy of Pediatrics Haemophilus influenzae infections and meningococcal infections. Red book 2012 report of the Committee on Infectious Diseases 2012, 348.503-348.504. American Academy of Pediatrics, Elk Grove Village (IL). L.K. Pickering, C.J. Baker, D.W. Kimberlin (Eds.)